Consensus document on the management of hyperkalemia

Nefrologia (Engl Ed). 2023 Nov-Dec;43(6):765-782. doi: 10.1016/j.nefroe.2023.12.002. Epub 2024 Jan 1.

Abstract

Hyperkalaemia is a common electrolyte imbalance with potentially serious short-, medium- and long-term consequences on morbidity and mortality rates and the use of national health service resources. The fact that different medical specialities can manage hyperkalaemia makes it important to have a unified approach, and the recent availability of new specific drug treatments means that the approach needs to be updated. This consensus document from the scientific societies most directly involved in the management of hyperkalaemia (Sociedad Española de Cardiología [Spanish Society of Cardiology], Sociedad Española de Endocrinología y Nutrición [Spanish Society of Endocrinology and Nutrition], Sociedad Española de Medicina Interna [Spanish Society of Internal Medicine], Sociedad Española de Medicina de Urgencias y Emergencias [Spanish Society of Accident and Emergency Medicine] and Sociedad Española de Nefrología [Spanish Society of Nephrology]) first of all reviews basic aspects of potassium balance and blood potassium. Then it goes on to focus on the concept, epidemiology, pathophysiology and diagnostic and therapeutic approaches to hyperkalaemia. The available evidence and the main published studies have been reviewed with the aim of providing a useful tool in the multidisciplinary approach to patients with hyperkalaemia.

Keywords: Chronic kidney disease; Ciclosilicato de sodio y zirconio; Diabetes mellitus; Enfermedad renal crónica; Heart failure; Hiperpotasemia; Hyperkalaemia; Insuficiencia cardiaca; Patiromer; Sodium zirconium cyclosilicate; Tratamiento; Treatment.

MeSH terms

  • Cardiology*
  • Consensus
  • Humans
  • Hyperkalemia* / diagnosis
  • Hyperkalemia* / drug therapy
  • Potassium
  • State Medicine

Substances

  • Potassium